Roussel-Uclaf's mifepristone (RU 486)
Roussel-Uclaf's mifepristone (RU 486): Study by Beatrice Couzinet, MD, et al, reported in the Dec. 18 issue of the New England Journal of Medicine finds that RU 486 caused termination of early pregnancy in 85% of 100 study participants. Investigators conclude that "the high frequency of complete abortion suggests that the efficacy of the drugt increases with shorter length of gestation." The study was limited to the first 10 days after expected onset of the missed menstrual period. Prolonged uterine bleeding occurred in 18% of the women. Couzinet, et al, note that the success rate with prostaglanding also approaches 85% but adds that prostaglandins are "associated with painful uterine contractions and gastrointestinal side effects in approximately 50% of subjects".
You may also be interested in...
Beckman Coulter is addressing the COVID-19 pandemic with various serology tests and diagnostics that will help physicians and drug developers treat patients with the virus. See what Beckman Coulter’s president, Julie Sawyer Montgomery, said about it here.
Gwyneth Paltrow’s Goop, Inc. demonstrated to the National Advertising Division’s satisfaction that Madame Ovary is “a daily regimen formulated to support thyroid health and smoothing the menopausal transition by providing nutritional support for women who may experience mild hot flashes, mood shifts, and stress-related fatigue.” Other ingredient-specific claims came up short.
Governor Cuomo will establish two panels, one examining safety and efficacy and another considering distribution and pricing, to advise the state on how to approach use of coronavirus vaccines once one is approved.